The global incidence of diabetes is approaching pandemic proportins, with the International Diabetes Federation predicting that approximately 4.4% (366 milion people) of the global population will have diabetes by the year 2030. Type 2 diabetes is expected to account for 90-95% of this number. Much evidence has clearly demonstrated that improving and maintaining good glycaemic control significantly reduces microvascular and macrovascular risks associated with diabetes. However, globally, target blood glucose levels are not achieved by the majority of patients, thus necessitating the establishment of the Global Task Force (GTF). The members of the GTE have commited to ...